Speaking Up and Speaking Out About Breast Cancer
How one woman is using her journey with the disease—and her experience with the Oncotype DX Breast Recurrence Score test—to help others.
Stay updated with breaking news from Recurrence Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
How one woman is using her journey with the disease—and her experience with the Oncotype DX Breast Recurrence Score test—to help others.
Investors should consider buying these Nasdaq stocks on the dip while they still can before the market reverses higher.
Phase 2 BRACELET-1 trial fully enrolled and advancing towards a randomized data readout that is expected to inform the design of a registrational study in...
Phase 2 BRACELET-1 trial fully enrolled and advancing towards a randomized data readout that is expected to inform the design of a registrational study in HR+/HER2- breast cancer Achieved
ADAPT Triad minimal residual disease analysis study intended to evaluate the association between circulating tumor DNA (ctDNA) positivity and recurrence intervals MADISON, Wis., Aug. 3